相关实验视频

Updated: Jun 11, 2025

A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

CD26在婴儿血液瘤的整个生命周期中表达不同,并表现出增殖阶段的特征

Bruno Lorusso¹, Antonella Nogara¹, Rodanthi Fioretzaki^1,2

¹Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.

International journal of molecular sciences

|September 28, 2024

概括

CD26是一种潜在的生物标志物,用于识别活跃的婴儿血瘤 (IHs). 这种标志物有助于区分增殖性肠道炎症病变和透性病变,有助于诊断和了解疾病进展.

科学领域:

血管生物学血管生物学
儿科瘤学儿科瘤学
皮肤病学皮肤病学

背景情况:

婴儿血管瘤 (IHs) 是常见的儿童血管瘤,具有明显的生命周期.
驱动IH扩散和卷积的细胞机制在很大程度上是未知的.
目前的诊断方法可能并不总是能区分活跃性和退行性内脏病.

研究的目的:

为了研究CD26在婴儿血管瘤中的作用.
确定潜在的生物标志物,以区分增殖性与涉及IH病变的生物标志物.
探索针对IH中CD26的治疗策略.

主要方法:

对27个IH组织样本 (增殖和涉及) 进行了免疫组织化学检查.
分析了包括CD31,GLUT1,WT1,nestin,CD133和CD26在内的标记物的表达.
原发性血管瘤衍生的内皮细胞 (Hem-ECs) 在体外用CD26抑制剂 (vildagliptin) 进行治疗.

主要成果:

所有IH表达CD31,GLUT1,WT1和nestin;没有表达D2-40.
CD26在增殖性IH病变中表达很高 (100%),但在涉及区域中缺席.
维尔达格利普丁治疗抑制了Hem-EC增殖和诱导细胞循环停止.
在一些IH样本中观察到共存的增殖和涉及特征.

结论:

CD26是一种有前途的生物标志物,用于识别多发性婴儿血管瘤.
CD26表达区分了活性IH与涉及IH的IH.
向CD26可能为非回归性内脏病提供治疗途径.

关键词:

CD133 是一个CD133 CD133 是一个CD133 在CD2626中,我们可以看到CD26.灭症 (apoptosis) 是一种死亡的过程.细胞循环中的细胞循环.它们是内皮细胞的内皮细胞.免疫组织化学免疫组织化学这是一个很好的选择. ki6767 ki6767 在p21中,p21是什么?它们的扩散和扩散.增殖性婴儿血管瘤婴儿血管瘤

更多相关视频

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Published on: April 12, 2018

Assessment and Characterization of Hyaloid Vessels in Mice

Assessment and Characterization of Hyaloid Vessels in Mice

Published on: May 15, 2019

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...